Tholstrup, Dorte <br/><br/>
Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily.  [electronic resource] 

 -  Leukemia & lymphoma  Mar 2011 
 - 400-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2010.541310  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Health Status<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Population<br/>Prednisone--administration & dosage<br/>Quality of Life<br/>Rituximab<br/>Time Factors<br/>Vincristine--administration & dosage